Do thyroglobulin antibodies above the reference range indicate autoimmune thyroid activity even if TPO antibodies are normal?

Thyroglobulin antibodies (TgAb) serve as critical markers of thyroid autoimmunity, particularly when standard screening tests do not provide a complete picture of immune status.

Clinical evidence

Research confirms that TgAb levels above the reference range are diagnostic markers for autoimmune thyroid disease (AITD).

• Hashimoto Thyroiditis (HT): TgAb is present in 70–80% of HT cases. While thyroid peroxidase antibodies (TPOAb) are more common, approximately 5–10% of HT patients are TPOAb-negative but TgAb-positive.
• Population Prevalence: In the general population, isolated TgAb positivity (elevated TgAb with normal TPOAb) occurs in a small but significant percentage of individuals, indicating "latent" or preclinical autoimmunity.
• Predictive Value: While TPOAb is a more sensitive predictor of future hypothyroidism, isolated TgAb still increases the risk of progression to overt thyroid dysfunction compared to antibody-negative individuals.

Mechanistic explanations

The presence of TgAb reflects a specific immune pathway targeting thyroid tissue:

• Lymphocytic Infiltration: TgAb positivity correlates histologically with chronic lymphocytic infiltration of the thyroid gland, the hallmark of Hashimoto thyroiditis. This process can occur even when other serological markers are absent.
• Immune Complexes: TgAb are IgG autoantibodies that bind to thyroglobulin, forming immune complexes. In clinical settings, these complexes can mask thyroglobulin (Tg) in sandwich assays, leading to falsely low or undetectable Tg measurements—a critical consideration for thyroid cancer patients.

Safety and clinical implications

The clinical significance of isolated TgAb elevation extends beyond initial diagnosis:

• Cancer Surveillance: In patients with differentiated thyroid carcinoma (DTC), TgAb serves as a surrogate tumor marker. Rising or de novo TgAb titers are highly suggestive of persistent or recurrent disease, even if imaging or Tg levels appear normal.
• Risk Modification: Some studies indicate that elevated pre-operative TgAb is independently associated with a higher probability of malignancy in patients with thyroid nodules.
• Diagnostic Limitations: Relying solely on TPOAb screening may fail to identify up to 10% of patients with seronegative Hashimoto's disease.

Bottom line

Elevated thyroglobulin antibodies are a validated indicator of autoimmune thyroid activity and frequently occur alongside normal thyroid peroxidase antibodies. While isolated TgAb is a less potent predictor of hypothyroidism than TPOAb, its presence confirms an underlying autoimmune process and necessitates clinical monitoring, especially in the context of thyroid cancer surveillance.